GlassScriptPhysician profile
Samuel L Scoma
NPI 1518450402
$859.05
in general payments reported to CMS, 2019-2025
15 companies · $232 in 2025
The $232 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.76 · 2021: $135 · 2022: $13.75 · 2023: $198 · 2024: $213 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $644.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $643.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $135.79 | 2021-2023 | Xarelto |
| Pfizer INC. | $115.72 | 2019-2024 | |
| Abiomed | $100.32 | 2024-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $96.26 | 2023-2024 | |
| Stryker Corporation | $90.26 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Clottriever Bold Catheter |
| Inari Medical, INC. | $88.13 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Recor Medical INC | $53.11 | 2024-2025 | Paradise Ultrasound Renal Denervation System, Paradise Renal Denervation System |
| Boston Scientific Corporation | $44.95 | 2024 | Watchman Flx |
| Astrazeneca Pharmaceuticals LP | $27.97 | 2022-2023 | Lokelma |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.09 | 2024 | Jardiance |
| Atricure, INC. | $18.78 | 2023 | |
| Smith+Nephew, INC. | $18.37 | 2025 | Collagenase Santyl |
| Abbott Laboratories | $16.44 | 2023 | Mitraclip |
| Bioxcel Therapeutics, INC. | $15.85 | 2023 | Igalmi |
| Alexion Pharmaceuticals, INC. | $13.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Scoma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.